January 4, 2018 / 12:14 PM / Updated 8 minutes ago BRIEF-Deciphera Pharma Initiates Late Stage Study In Gastrointestinal Cancer Patients Reuters Staff 1 Min Read 
Jan 4 (Reuters) - Deciphera Pharmaceuticals Inc: 
* DECIPHERA PHARMACEUTICALS INITIATES PHASE 3 CLINICAL STUDY WITH DCC-2618 IN PATIENTS WITH ADVANCED GASTROINTESTINAL STROMAL TUMORS (“INVICTUS” STUDY) 
* DECIPHERA PHARMACEUTICALS - EXPECT TO REPORT TOP-LINE RESULTS IN 2019 AND, IF SUCCESSFUL, THE PHASE 3 STUDY COULD SERVE AS BASIS FOR NDS Source text for Eikon: Further company coverage: